SunTrust Robinson Humphrey Initiates Coverage On Deciphera Pharmaceuticals with Buy Rating, Announces $77 Price Target

SunTrust Robinson Humphrey analyst Robyn Karnauskas initiates coverage on Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Buy rating and a $77 price target.

Benzinga · 01/13/2020 13:41

SunTrust Robinson Humphrey analyst Robyn Karnauskas initiates coverage on Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Buy rating and a $77 price target.